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Abstract In the study presented here a LightCycler real-
time PCR system was used for the diagnosis of fungal
infections from clinical tissue samples. Nine specimens
were investigated from six patients with suspected or
proven invasive fungal infections. Seven of nine samples
were positive in a broad-range fungal PCR assay. In four
samples, Aspergillus fumigatus was detected both by a
species-specific hybridization assay as well as by se-
quencing of amplification products. In addition, the
broad-range fungal PCR assay and PCR sequencing
detected and identified, respectively, the following or-
ganisms in the specimens noted: Candida albicans in a
culture-negative liver biopsy, Histoplasma capsulatum in
a bone marrow sample, and Conidiobolus coronatus in a
facial soft tissue specimen. Real-time PCR is a promising
tool for the diagnosis of invasive fungal infections in
human tissue samples and offers some advantages over
culture methods, such as rapid analysis and increased
sensitivity.
Introduction
Invasive fungal infections have become a major cause of
infection-related morbidity and mortality after aggressive
chemotherapy, organ transplantation, or in patients with
immunodeficiency syndromes. Early diagnosis, prompt
initiation of appropriate therapy, and restoration of
immunocompetence are crucial for the successful man-
agement of these life-threatening conditions [1]. Howev-
er, the timely and accurate diagnosis of fungal infections
using conventional microbiologic and histopathologic
techniques is time-consuming and difficult due to the
suboptimal sensitivity and/or specificity of these methods
[2, 3].
Therefore, efforts are ongoing to develop rapid and
sensitive non-culture-based diagnostic strategies such as
the detection of fungal antigens, fungal metabolic prod-
ucts, and amplification of specific fungal nucleic acid
sequences by PCR [4, 5]. Recently, a variety of PCR
methods based on the detection of fungal DNA in
otherwise sterile human fluids or tissue samples have
been described [6, 7, 8, 9, 10], and these appear promising
for improving the sensitivity and diagnostic accuracy of
invasive fungal infection testing methods. PCR assays
that amplify fungi-specific and highly conserved se-
quences of multi-copy genes (e.g. the 18S rRNA gene) are
clinically useful for the detection of fungal infections,
whereas assays targeting species-specific sequences are
used to identify the pathogen. However, species identi-
fication often requires time-consuming blotting proce-
dures with a sequential hybridization reaction [5].
Recently, a quantitative PCR assay utilizing the Light-
Cycler amplification and detection system (Roche Diag-
nostics, Switzerland) was developed that allowed species
determination of fungal DNA in human blood samples,
thereby significantly reducing the amount of time and
labor required for diagnosis [9].
In this report, we show that this convenient diagnostic
approach is also applicable to the analysis of human tissue
samples from deep-seated fungal infections. Furthermore,
we adapted a PCR assay with broad-range fungal primers
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that uses SYBR green for amplification of DNA. Subse-
quent sequencing of the amplicon allowed identification
of the pathogen.
Materials and Methods
A total of nine tissue specimens from liver, lung, brain, bone
marrow, or facial soft tissue, were obtained from six patients with
suspected or proven invasive fungal infections (Table 1). Under-
lying diseases were aggressive chemotherapy for hematological
malignancies in three patients (no. 1, 2, and 4), long-term therapy
with corticosteroids for lupus nephritis in one patient (no. 3), and
diabetes mellitus in one patient (no. 6). Patient number 5 had
reactivation of histoplasmosis.
To enhance disruption of fungal cell walls, tissue specimens
were freeze-thawed four times rapidly by freezing the samples in
liquid nitrogen for 1 min followed by thawing at 95C for 2 min.
Samples were then incubated with recombinant lyticase (Sigma,
Switzerland) and treated with proteinase K. The lyticase step turned
out to be unnecessary for DNA extraction (data not shown) and was
omitted in specimens from patients 1, 3 and 6 (Table 1). Instead of
the lyticase step, samples were sonicated for 15 min at 47 kHz at
room temperature in a sonicator bath (Branson, model 2510). DNA
isolation was carried out using the high pure PCR template
purification kit (Roche Diagnostics) according to the manufactur-
er’s instructions. As negative controls, ddH2O and sterile spleen
tissue were processed in parallel in each assay. Purified DNA
samples were stored at 20C until analysis.
The LightCycler PCR and detection system (Roche Diagnos-
tics) was used for amplification and real-time quantification of
DNA with previously described broad-range fungal primers and a
species-specific probe for Aspergillus fumigatus [9]. Briefly, for
detection of fungal species (broad-range fungal PCR), a primer set
(forward primer: 50-ATT GGA GGG CAA GTC TGG TG; reverse
primer: 50-CCG ATC CCT AGT CGG CAT AG; Microsynth,
Switzerland) was used that binds to a highly conserved region of
the fungal multicopy 18S rRNA gene [9]. The human beta-globin
gene served as an internal control (forward primer: 50-GAA GAG
CCA AGG ACA GGT AC-30; and reverse primer: 50-CCA CTT
CAT CCA CGT TCA CC-30). PCR for beta-globin was performed
in separate reactions within the same run with SYBR green mix as
described previously [11]. For amplicon detection, the LightCycler
DNA master SYBR green kit was used according to the manufac-
turer’s instructions. For identification of Aspergillus fumigatus,
oligonucleotides that hybridize to an internal species-specific
sequence of the 18S rRNA gene (probe 1: labeled at the 50 end
with the LightCycler Red 640 fluorophore-TGA GGT TCC CCA
GAA GGA AAG GTC CAG C; probe 2: labeled at the 30 end with
fluorescein-GTT CCC CCC ACA GCC AGT GAA GGC; both
from TIB MOLBIOL, Germany) were used with the LightCycler
DNA master hybridization probe kit as described by the manufac-
turer.
Amplification reactions were performed in a total volume of
20 l containing either 1 FastStart SYBR green reaction mix and
enzyme or LightCycler hybridization mix and enzyme, 4 mM
MgCl2, and 1 M of each flanking primer for broad-range fungal
PCR or additional 1 M hybridization probes and 2 l of sample
DNA. Preincubation at 95C for 10 min was followed by 40 cycles
of repeated denaturation (1 s at 95C), annealing (18 s at 62C), and
enzymatic chain extension (30 s at 72C). Thirty-two samples were
run in parallel. Melting-curve analysis was performed in the range
of 70–98C to confirm that a single DNA PCR product was
generated from the DNA template. Amplicons obtained with the
broad-range fungal PCR were sequenced (Microsynth), and the
sequences were compared to 18S rRNA genes available in the
GenBank database.
Results and Discussion
Table 1 summarizes the results from microscopy, culture,
PCR assays, and sequencing of amplification products for
all nine specimens from six patients. Broad-range fungal
PCR revealed a positive result in seven of the nine
specimens tested. The two PCR-negative samples were
also negative in either direct microscopy or culture
(Table 1).
The broad-range fungal primer set used herein targets a
highly conserved sequence of the fungal 18S rRNA gene
[9]. This ribosomal gene was chosen because the rRNA
region exists in multiple copies within the fungal genome
Table 1 Results from PCR assays, PCR amplicon sequencing, direct microscopy, and culture performed on nine clinical samples obtained
from six patients with suspected or proven invasive fungal infections
Patient no./
sample source
Direct
microscopy
SYBR
green
Hybridization probe
(A. fumigatus)
Culture Sequencing
1
Brain abscess mm ++ positive positive A. fumigatus A. fumigatus
Sinus mm + positive positive negative not done
Sinus (not infected) mm – negative
2
Lung biopsy mm +++ positive positive A. fumigatus A. fumigatus
3
Liver biopsy ym +, yc ++ positive not done negative C. albicans
4
Eye negative positive positive A. fumigatus A. fumigatus
Lung biopsy negative negative
5
Bone marrow yc ++ positive not done H. capsulatum H. capsulatum
6
Soft tissue mm ++ positive not done Conidiobolus sp. C. coronatus
Mm, mold mycelium; ym, yeast mycelium; yc, yeast cells; +, a few elements; ++, clearly visible structures; +++, crowded samples
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[12, 13], thus providing increased amplification of the
signal compared to single copy genes. It is important to
note that some members of the zygomycetes such as
Rhizopus and Rhizomucor spp. have different 18S rRNA
sequences and are not detected with this primer set [14].
Therefore, the term “panfungal” used by others is
misleading [6]. Previously, it has been demonstrated that
the LightCycler system facilitates the detection of fungal
species in human blood with a sensitivity that is
comparable to conventional PCR [9]. Herein, we extend
these findings by showing reliable detection of fungi in
human tissue samples in the clinical setting. This real-
time PCR approach further obviates the need for gel
electrophoresis, thereby reducing the time required until a
result is obtained and minimizing the risk of cross-
contamination of amplification products.
Identification of fungal species can be achieved by two
different means: (i) by hybridization with species-specific
probes or (ii) by direct sequencing of amplicons. Using
melting curve analysis, amplicons yielded single products
with the following defined melting temperatures: Asper-
gillus spp. 90C, Candida spp. 86C, Conidiobolus spp.
88C and Histoplasma spp. 92C. Loeffler et al. [8]
previously demonstrated accurate identification of fungal
species in human blood using the LightCycler-based
technique with probes that target an internal species-
specific sequence of the 18S rRNA gene. Our data show
that this method can successfully be applied to human
tissue samples as well. In all three patients with culture-
proven Aspergillus fumigatus infection, the hybridization
assay gave a positive result (Table 1). One sample that
was culture-negative gave a positive result by hybridiza-
tion probe analysis (Table 1).
For six of the nine specimens tested, amplification
products were sequenced and the results were compared
with the GenBank database. Sequencing results not only
confirmed the presence of Aspergillus fumigatus infection
in these three patients, but was also in agreement with the
result of culture in another patient infected with Histo-
plasma capsulatum. Furthermore, the amplicon identified
one organism that did not grow in culture (Candida
albicans), and identified the Conidiobolus organism
growing in one sample to the species level as Conidiobo-
lus coronatus. The zygomycete Conidiobolus typically
infects mucocutaneous sites to produce sinusitis.
Limitations of PCR include the generation of both
false-positive and false-negative results. These issues are
addressed in several ways, including standardization of
technical procedures and use of internal controls [15].
Impurities in nucleic acid preparations (e.g. ethanol) or in
biological samples (e.g. hemoglobin or heparin) can
inhibit PCR amplification or reduce its sensitivity. In our
study, we used the human beta-globin gene as a positive
control to verify successful DNA amplification. False-
positive results can stem from contamination of lyticase
with fungal DNA, as described previously [9]. In our
protocol, lyticase treatment was not necessary for the
successful extraction of fungal DNA and could be
omitted.
The diagnosis of invasive fungal infections is tradi-
tionally established by culture, microscopy of clinical
specimens or histology. However, light microscopy of
fungal smears is ambiguous in many cases, and culture
has a low sensitivity and is time-consuming, requiring up
to several weeks until the final diagnosis is reached.
Typically, a real-time PCR result is generated within a
few hours, which is significantly earlier than culture
results. Although the costs of PCR generally exceed those
of conventional culture methods and may currently limit
its widespread use, earlier and more sensitive diagnosis
could eventually decrease the high mortality of fungal
infections in immunocompromised patients. Thus, PCR
technology, including real-time approaches such as the
one presented here, offers valuable options for the rapid
detection and identification of fungi.
References
1. Haynes KA, Westerneng TJ, Fell JW, Moens W (1995) Rapid
detection and identification of pathogenic fungi by polymerase
chain reaction amplification of large subunit ribosomal DNA. J
Med Vet Mycol 33:319–325
2. Duthie R, Denning DW (1995) Aspergillus fungemia: report of
two cases and review. Clin Infect Dis 20:598–605
3. Gottfredsson M, Cox GM, Perfect JR (1998) Molecular
methods for epidemiological and diagnostic studies of fungal
infections. Pathology 30:405–418
4. Walsh TJ, Chanock SJ (1998) Diagnosis of invasive fungal
infections: advances in nonculture systems. Curr Clin Top
Infect Dis 18:101–153
5. Yeo SF, Wong B (2002) Current status of nonculture methods
for diagnosis of invasive fungal infections. Clin Microbiol Rev
15:465–484
6. Hendolin PH, Paulin L, Koukila-Kahkola P, Anttila VJ,
Malmberg H, Richardson M, Ylikoski J (2000) Panfungal
PCR and multiplex liquid hybridization for detection of fungi in
tissue specimens. J Clin Microbiol 38:4186–4192
7. Jaeger EE, Carroll NM, Choudhury S, Dunlop AA, Towler HM,
Matheson MM, Adamson P, Okhravi N, Lightman S (2000)
Rapid detection and identification of Candida, Aspergillus, and
Fusarium species in ocular samples using nested PCR. J Clin
Microbiol 38:2902–2908
8. Loeffler J, Hebart H, Cox P, Flues N, Schumacher U, Einsele H
(2001) Nucleic acid sequence-based amplification of Aspergil-
lus RNA in blood samples. J Clin Microbiol 39:1626–1629
9. Loeffler J, Henke N, Hebart H, Schmidt D, Hagmeyer L,
Schumacher U, Einsele H (2000) Quantification of fungal DNA
by using fluorescence resonance energy transfer and the light
cycler system. J Clin Microbiol 38:586–590
10. Rickerts V, Loeffler J, B-hme A, Einsele H, Just-Nbling G
(2001) Diagnosis of disseminated zygomycosis using a poly-
merase chain reaction assay. Eur J Clin Microbiol Infect Dis
20:744–745
11. Zinkernagel AS, Gmur R, Fenner L, Schaffner A, Schoedon G,
Schneemann M (2003) Marginal and subgingival plaque—a
natural habitat of Tropheryma whipplei? Infection 31:86–91
12. Olsen GJ, Woese CR (1993) Ribosomal RNA: a key to
phylogeny. FASEB J 7:113–123
13. Maleszka R, Clark-Walker GD (1993) Yeasts have a four-fold
variation in ribosomal DNA copy number. Yeast 9:53–58
14. Kappe R, Okeke CN, Fauser C, Maiwald M, Sonntag HG
(1998) Molecular probes for the detection of pathogenic fungi
in the presence of human tissue. J Med Microbiol 47:811–820
15. Fredricks DN, Relman DA (1999) Application of polymerase
chain reaction to the diagnosis of infectious diseases. Clin
Infect Dis 29:475–486
560
